Spiropyrrolidine derived antiviral agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11912714
APP PUB NO 20230151019A1
SERIAL NO

17983501

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ENANTA PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cao, Hui Belmont, US 129 1542
Gao, Xuri Newtonville, US 46 556
Kass, Jorden Arlington, US 28 398
Li, Wei Lexington, US 2027 12741
Or, Yat Sun Waltham, US 406 6269
Peng, Xiaowen Sudbury, US 70 1621
Shen, Ruichao Belmont, US 65 620
Wang, Guoqiang Belmont, US 208 2629
Zhang, Jiajun Cambridge, US 23 155

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 27, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 27, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 27, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00